US 5,688,653 A · 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor

Abstract

The present invention relates to advanced glycosylation endproducts (AGEs), and particularly to novel cyclopentenone aminoreductones, 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-ones. Such AGEs can be used in various diagnostic and therapeutic methods.

Claims3

Dependent claims

A compound of the formula ##STR6## wherein R is a lower alkyl group containing from 1 to 6 carbon atoms.

Dependencies are inferred from the claim text.

Facts

Application

08/673,217Filed 27 Jun 1996

Granted

18 Nov 1997

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07C 225/20
Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms…:…
G01N 33/5308
Immunoassay; Biospecific binding assay; Materials therefor: for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
G01N 33/573
Immunoassay; Biospecific binding assay; Materials therefor: for enzymes or isoenzymes
G01N 33/723
Haemoglobin: glycosylated haemoglobin

3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor

Life of this patent

Abstract

Claims3

3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor

Life of this patent

Abstract

Claims3